Grifols SA (GIFLF)
11.13
0.00 (0.00%)
USD |
OTCM |
Sep 18, 16:00
Grifols Price : 11.13 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 11.13 | 11.13 | 11.13 | 11.13 | 0.000 |
| Sep 17, 2026 | 11.13 | 11.13 | 11.13 | 11.13 | 0.000 |
| Sep 16, 2026 | 11.13 | 11.13 | 11.13 | 11.13 | 0.000 |
| Sep 15, 2026 | 11.13 | 11.13 | 11.13 | 11.13 | 5000.00 |
| Sep 14, 2026 | 11.33 | 11.33 | 11.33 | 11.33 | 0.000 |
| Sep 11, 2026 | 11.33 | 11.33 | 11.33 | 11.33 | 0.000 |
| Sep 10, 2026 | 11.33 | 11.33 | 11.33 | 11.33 | 7000.00 |
| Sep 09, 2026 | 11.08 | 11.08 | 11.08 | 11.08 | 0.000 |
| Sep 08, 2026 | 11.08 | 11.08 | 11.08 | 11.08 | 0.000 |
| Sep 04, 2026 | 11.08 | 11.08 | 11.08 | 11.08 | 4300.00 |
| Sep 03, 2026 | 11.76 | 11.76 | 11.76 | 11.76 | 0.000 |
| Sep 02, 2026 | 11.76 | 11.76 | 11.76 | 11.76 | 0.000 |
| Sep 01, 2026 | 11.76 | 11.76 | 11.76 | 11.76 | 0.000 |
| Aug 31, 2026 | 11.76 | 11.76 | 11.76 | 11.76 | 0.000 |
| Aug 28, 2026 | 11.76 | 11.76 | 11.76 | 11.76 | 0.000 |
| Aug 27, 2026 | 11.76 | 11.76 | 11.76 | 11.76 | 0.000 |
| Aug 26, 2026 | 11.76 | 11.76 | 11.76 | 11.76 | 0.000 |
| Aug 25, 2026 | 11.76 | 11.76 | 11.76 | 11.76 | 0.000 |
| Aug 24, 2026 | 11.76 | 11.76 | 11.76 | 11.76 | 0.000 |
| Aug 21, 2026 | 11.76 | 11.76 | 11.76 | 11.76 | 0.000 |
| Aug 20, 2026 | 11.76 | 11.76 | 11.76 | 11.76 | 0.000 |
| Aug 19, 2026 | 11.76 | 11.76 | 11.76 | 11.76 | 0.000 |
| Aug 18, 2026 | 11.76 | 11.76 | 11.76 | 11.76 | 0.000 |
| Aug 17, 2026 | 11.76 | 11.76 | 11.76 | 11.76 | 0.000 |
| Aug 14, 2026 | 11.76 | 11.76 | 11.76 | 11.76 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Pharma Mar SA | 94.60 |
| Oryzon Genomics SA | 3.31 |
| Agenus, Inc. | 7.85 |
| Amgen, Inc. | 385.65 |
| Anika Therapeutics, Inc. | 20.81 |
Price Related Metrics
| PE Ratio | 14.36 |
| PS Ratio | 0.875 |
| PEG Ratio | 0.2329 |
| Price to Book Value | 1.195 |
| Price to Free Cash Flow | 10.07 |
| Earnings Yield | 6.96% |
| Market Cap | 7.575B |
| PEGY Ratio | 0.2241 |
| Operating PE Ratio | 5.391 |
| Normalized PE Ratio | 14.36 |